MWA Asset Management Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

MWA Asset Management increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,809 shares of the healthcare conglomerate’s stock after acquiring an additional 93 shares during the period. UnitedHealth Group makes up 1.3% of MWA Asset Management’s investment portfolio, making the stock its 23rd largest position. MWA Asset Management’s holdings in UnitedHealth Group were worth $1,927,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the stock. M&T Bank Corp grew its position in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC raised its holdings in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after buying an additional 1,193 shares during the period. Benjamin Edwards Inc. grew its stake in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC raised its position in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. KeyCorp reiterated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Down 0.6 %

NYSE:UNH opened at $526.68 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market capitalization of $484.69 billion, a PE ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50 day moving average of $530.85 and a 200-day moving average of $564.52.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.